Mackenzie Financial
RYTM icon

Mackenzie Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Mackenzie Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
+10,936
New +$989K ﹤0.01% 1158
2026
Q1 		– Sell
-4,398
Closed -$469K – 1709
2025
Q4 		$469K Hold
4,398
– – ﹤0.01% 1236
2025
Q3 		$444K Sell
4,398
-13
-0.3% -$1.21K ﹤0.01% 1278
2025
Q2 		$279K Buy
4,411
+68
+2% +$4.16K ﹤0.01% 1427
2025
Q1 		$230K Hold
4,343
– – ﹤0.01% 1469
2024
Q4 		$243K Hold
4,343
– – ﹤0.01% 1472
2024
Q3 		$228K Buy
+4,343
New +$208K ﹤0.01% 1320

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mackenzie Financial's RYTM Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 10,936 shares worth $1.21M. The stake represents ﹤0.01% of the portfolio and ranks #1158 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in RYTM as recently as Q4 2025.

Mackenzie Financial first reported a position in RYTM in Q3 2024 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Mackenzie Financial held 10,936 shares of Rhythm Pharmaceuticals worth $1.21M as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Mackenzie Financial position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1158 holding.
  • Mackenzie Financial first reported a position in Rhythm Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.